The GPhC has a role to play in ensuring public protection, but it is notable that it has changed its own behaviour.
Letters to the editor
The long-term trusting relationship with community pharmacy staff and the on-going reason to attend the pharmacy were key factors in this success.
Managed repeat prescriptions have been being phased out for some time now and if stockpiling is still an issue, what else can be done?
In terms of making sure this type of case never happens again, we simply cannot achieve this by ourselves.
The community pharmacy platform in England is just not set up to deliver these interventions robustly at scale.
I believe patients are being put at risk due to how repeat prescription services are being managed.
I think the excessive accumulation of prescription medication is a common occurrence and I have seen this in practice.
I believe to prevent such case as this happening again there should be no ordering of prescriptions without the prior informed consent of the patient.
I do not agree with the GPhC suggesting that COVID-19 rapid antibody tests should not be supplied by community pharmacies across the country.
I do not think that community pharmacies should have the ability to order prescriptions on behalf of people. I have seen that system abused many times.